🇺🇸 FDA
Drug

pembrolizumab

Brand: KEYTRUDA QLEX

approved

Quick answer

pembrolizumab (KEYTRUDA QLEX), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
pembrolizumab
Brand
KEYTRUDA QLEX
Route
INJECTION
Formulation
INJECTABLE

Related news

FDA Approves Keytruda for Adjuvant Treatment of Stage III Melanoma
NewsoncologyApr 9, 2026

FDA Approves Keytruda for Adjuvant Treatment of Stage III Melanoma

The FDA has granted approval for Keytruda as an adjuvant treatment for patients with Stage III melanoma, marking a significant advancement in cancer therapy.

Dr. Sarah Mitchell

Frequently asked questions

What is pembrolizumab?

pembrolizumab (KEYTRUDA QLEX), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for pembrolizumab?

KEYTRUDA QLEX is a marketed brand name for pembrolizumab. Check FDA Drugs@FDA for the current US label holder.